PLSE vs PSX · rev $835.0K vs P/E 17, rev $83.54B
Pulse Biosciences Inc (PLSE) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Pulse Biosciences Inc (PLSE) is a medical instruments & supplies company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported PLSE revenue for 2026-06-30 was $835.0K. Net income was -$43.2M. PLSE currently screens at market cap $1.03B.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
PLSE currently screens at market cap $1.03B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the PLSE and PSX stock pages for the full models.
Not investment advice.